Prostate cancer is a dark and mysterious country, and the authors Ralph H. Blum and Dr. Mark Scholz are good, levelheaded guides through these thickets.
Research from investigators at Rutgers Cancer Institute of New Jersey; University of California, Los Angeles; University of California, Santa Cruz and other institutions shows a computational approach examining abnormal "signaling" in...Show More Summary
(Reuters) - Pfizer Inc, beating out numerous other bidders, said it would buy U.S. cancer drug company Medivation Inc for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company's growing oncology rost...
Pfizer buying prostate cancer specialist Medivation for $14B; ex-NBA star Kobe Bryant to launch venture capital fund; and heavy flooding threatens U.S. rice harvest. These headlines and more from CBS MoneyWatch.
Company is best known for its prostate cancer drug Xtandi
Early prostate cancer diagnoses are on the decline in the U.S., following the U.S. Preventive Services Task Force recommendation against routine screening. Screening for prostate cancer involves a blood test for identifying the levels of prostate specific antigen (PSA) produced … The post Early prostate cancer diagnoses on the decline in the U.S. Show More Summary
Incidence rates of early prostate cancer have continued to drop since the U.S. Preventive Services Task Force recommendation against routine prostate-specific antigen (PSA) testing in all men, according to an article published online by JAMA Oncology. The USPSTF recommendation was released in draft form in 2011 and in final form in 2012. Show More Summary
Political talk show pioneer John McLaughlin died Tuesday morning at his home in Virginia at the age of 89, the New York Daily News reports. According to the Washington Post, he had been fighting prostate cancer. After stints as a Catholic priest and speechwriter for President Nixon, McLaughlin started The...
Prostate cancer, Alzheimer's, Parkinson's...these three diseases are associated with proteins that share a common feature, namely disordered regions that have no apparent rigid three-dimensional structure. In spite of the potential of these regions as therapeutic targets, it was believed that drugs could not be directed to them. Show More Summary
(TORONTO, Canada - Aug. 15, 2016) - Prostate cancer researchers studying genetic variations have pinpointed 45 genes associated with disease development and progression. read more
Prostate cancer treatment decisions If the first therapy to treat prostate cancer doesn't work, there are other options available — with one exception. Having all the information is a blessing and a curse According to Lonnie Fynskov, a Mayo Clinic nurse and patient educator, being a cancer nurse is helpful in understanding what’s happening when […]
Researchers believe that a non-invasive screening test that can identify genetic markers for high-grade prostate cancer in urine may eventually reduce the number of prostate biopsies needed. However, experts also caution that while the...Show More Summary
Study maps out abnormal signaling pathways in prostate cancer cells and provides computational approaches to identify individualized targets for therapy
Sanford Burnham Prebys Medical Discovery Institute (SBP) has received a $1M donation from The Epstein Family Foundation for scientists to study pancreatic and prostate cancer. The gift, contributed by SBP board member Dan Epstein and...Show More Summary
“‘It’s André’s wish that we be straight about that,” said his manager Linda Marder … “Men of a certain age have this problem.’ Survival rates are very high. The diagnosis was made only weeks ago, … [and Watts] has been to the Mayo Clinic to determine treatment.”
A prostate cancer survivor, the bestselling author advises men over 40 to get a PSA exam as the simple first step in diagnosing the diseaseand maybe saving your life.
Men with very high-risk prostate cancer, who are treated at hospitals with a high proportion of administered radical local treatment (radiotherapy or prostatectomy), only have half of the mortality risk of men who are treated at hospitals with the lowest proportion. Show More Summary
In the search for new ways to attack recurrent prostate cancer, researchers at Duke Health report that a novel compound appears to have a unique way of blocking testosterone from fueling the tumors in mice.
Andre Watts has cancelled the Philadelphia Orchestra before, but this time he has a serious cause. He was diagnosed three weeks ago with prostate cancer. ‘It’s Andre’s wish that we be straight about that,’ said his manager Linda Marder. Andre, 70, got his career break in 1963 when Leonard Bernstein asked him to step in […]
Black men taking androgen deprivation therapy were more likely to die than white men.